Second Malignancy Risks in Hodgkin's Disease Patients
Author Information
Author(s): AJ Swerdlow, JA Barber, A Horwich, D Cunningham, S Milan, RZ Omar
Primary Institution: Royal Marsden Hospital
Hypothesis
Does treatment for Hodgkin's disease increase the risk of second malignancies?
Conclusion
Patients treated for Hodgkin's disease have a significantly increased risk of developing second malignancies, particularly solid cancers.
Supporting Evidence
- 77 second malignancies occurred among the cohort.
- Significantly raised risks were found for stomach, lung, bone, soft tissue, and non-melanoma skin cancers.
- Leukaemia risk was significantly raised in patients receiving chemotherapy.
- The relative risk of second cancers was much greater in patients treated at younger ages.
Takeaway
Kids who get treated for Hodgkin's disease might get sick again later with different types of cancer, especially if they were younger when they were treated.
Methodology
Data was collected from 1039 patients treated for Hodgkin's disease from 1963 to 1991, with follow-up for second malignancies until June 1991.
Potential Biases
Potential biases may arise from the retrospective nature of the study and reliance on cancer registry data.
Limitations
The study may not account for all variables affecting cancer risk, and some patients were excluded due to incomplete follow-up.
Participant Demographics
649 men and 390 women, mostly under 45 years old at first treatment.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% Cl
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website